Now students going abroad should not worry about the quarantine expenses, Vaccine King Adar Poonawalla will help, apply like this

Now students going abroad should not worry about the quarantine expenses, Vaccine King Adar Poonawalla will help, apply like this

Poonawalla wrote on Twitter, “Dear students going abroad, since some countries have not yet approved Kovidshield as an acceptable vaccine for travel without quarantine, you may have to spend some money.

Adar Poonawala, CEO of Serum Institute Company

Adar Poonawalla, CEO and owner of Serum Institute of India, said that he has set aside Rs 10 crore to help students going abroad for studies, as some countries have so far imposed quarantine. Covishield is not approved as an acceptable vaccine for non-admission. Poonawalla has given this information by tweeting.

Poonawalla wrote on Twitter, “Dear students going abroad, since some countries have not yet approved Kovidshield as an acceptable vaccine for travel without quarantine, you may have to spend some money. I have set aside Rs 10 crore for this. He also shared a link where students can apply for financial assistance if needed.

16 European countries approve Kovishield

Adar had earlier, in July, commended 16 European countries for recognizing Covishield as an acceptable vaccine for entry. Poonawalla has donated 1 million pounds for a crowdfunding scheme started by a news channel. Even though India has been moved from the Red List to the Amber List in the UK, students will still have to be quarantined for 10 days at a place of their choice.

Only people who have been fully vaccinated in the UK, EU or USA will be exempt from quarantine, which means they will have had the Pfizer, Moderna, AstraZeneca, or Johnson & Johnson vaccines.

Although Covishield has emergency use approval from the World Health Organization (WHO), it has not yet received approval from the European Medicines Agency. Currently, the vaccine is being accepted by more than 30 countries. The other vaccine currently in use in India, Bharat Biotech’s Covaxin, is yet to receive an emergency use list from the WHO.

read this also-

Shares of Vodafone Idea pauped investors, 10926 crores sunk in 4 days, stock lost 45%

.

Default image
Business Khabar
We aim to constantly bring to you all the latest and most updated industry news across all major categories. With a wide variety of topics and categories under our umbrella, we bring to you the latest news and activities in the top sought areas of public interest.
Articles: 5409